These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22876919)

  • 1. Therapeutic perspectives for adiponectin: an update.
    Li FY; Lam KS; Xu A
    Curr Med Chem; 2012; 19(32):5513-23. PubMed ID: 22876919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and cardiovascular health: an update.
    Hui X; Lam KS; Vanhoutte PM; Xu A
    Br J Pharmacol; 2012 Feb; 165(3):574-90. PubMed ID: 21457225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the heart: the protective role of adiponectin.
    Caselli C; D'Amico A; Cabiati M; Prescimone T; Del Ry S; Giannessi D
    Pharmacol Res; 2014 Apr; 82():9-20. PubMed ID: 24657240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
    Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines: a link between obesity and cardiovascular disease.
    Nakamura K; Fuster JJ; Walsh K
    J Cardiol; 2014 Apr; 63(4):250-9. PubMed ID: 24355497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk.
    Tumminia A; Vinciguerra F; Parisi M; Graziano M; Sciacca L; Baratta R; Frittitta L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into adiponectin role in obesity and obesity-related diseases.
    Nigro E; Scudiero O; Monaco ML; Palmieri A; Mazzarella G; Costagliola C; Bianco A; Daniele A
    Biomed Res Int; 2014; 2014():658913. PubMed ID: 25110685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes.
    Chen B; Lam KS; Wang Y; Wu D; Lam MC; Shen J; Wong L; Hoo RL; Zhang J; Xu A
    Biochem Biophys Res Commun; 2006 Mar; 341(2):549-56. PubMed ID: 16427606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin as a Target in Obesity-related Inflammatory State.
    Ohashi K; Yuasa D; Shibata R; Murohara T; Ouchi N
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):145-50. PubMed ID: 25772181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.
    Xu A; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1231-40. PubMed ID: 22210749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and cardiovascular disease.
    Shibata R; Ouchi N; Murohara T
    Circ J; 2009 Apr; 73(4):608-14. PubMed ID: 19261992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
    Achari AE; Jain SK
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory assessment of cardiometabolic risk in overweight and obese children.
    Sypniewska G
    Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin.
    Hossain MM; Mukheem A; Kamarul T
    Life Sci; 2015 Aug; 135():55-67. PubMed ID: 25818192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin: a key player in obesity related disorders.
    Matsuzawa Y
    Curr Pharm Des; 2010 Jun; 16(17):1896-901. PubMed ID: 20370675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy.
    Gómez-Ambrosi J; Catalán V; Rodríguez A; Andrada P; Ramírez B; Ibáñez P; Vila N; Romero S; Margall MA; Gil MJ; Moncada R; Valentí V; Silva C; Salvador J; Frühbeck G
    Diabetes Care; 2014 Oct; 37(10):2813-21. PubMed ID: 25011950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.